Hutch News

Scientists see foam as starting point of a path to bedside gene therapy

Scientists see foam as starting point of a path to bedside gene therapy

Bioengineer Dr. Matthias Stephan developed a quick-foaming solution that he hopes could one day turn gene therapy into an outpatient procedure
Hutch NewsNovember 17, 2025
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo

Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo

Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
Hutch NewsMay 20, 2025
Iniciativa para llevar la genoterapia a países de bajos ingresos

Iniciativa para llevar la genoterapia a países de bajos ingresos

Del Laboratorio Adair, División de Ciencias Traslacionales y Terapéuticas
Science SpotlightSeptember 18, 2024
Taking a frothy risk to advance gene therapy

Taking a frothy risk to advance gene therapy

Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Hutch NewsJune 03, 2024
Could a medicated foam make gene therapies more accessible?

Could a medicated foam make gene therapies more accessible?

In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.
News ReleasesMay 29, 2024
‘If you want to go far, go together’

‘If you want to go far, go together’

Fred Hutch scientist Dr. Jennifer Adair partners with colleagues around the globe to make gene therapies more effective and more widely available
Hutch NewsMay 08, 2024